Prestige Consumer Healthcare EBITDA Margin 2010-2025 | PBH
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Prestige Consumer Healthcare (PBH) over the last 10 years. The current EBITDA margin for Prestige Consumer Healthcare as of June 30, 2025 is .
| Prestige Consumer Healthcare EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2025-06-30 | $1.12B | $0.37B | 32.83% |
| 2025-03-31 | $1.14B | $0.37B | 32.43% |
| 2024-12-31 | $1.12B | $0.37B | 32.65% |
| 2024-09-30 | $1.11B | $0.36B | 32.58% |
| 2024-06-30 | $1.11B | $0.37B | 32.88% |
| 2024-03-31 | $1.13B | $0.38B | 33.69% |
| 2023-12-31 | $1.13B | $0.02B | 1.41% |
| 2023-09-30 | $1.13B | $0.02B | 1.42% |
| 2023-06-30 | $1.13B | $0.01B | 1.15% |
| 2023-03-31 | $1.13B | $0.02B | 1.33% |
| 2022-12-31 | $1.11B | $0.37B | 33.63% |
| 2022-09-30 | $1.11B | $0.37B | 33.33% |
| 2022-06-30 | $1.09B | $0.36B | 33.09% |
| 2022-03-31 | $1.09B | $0.37B | 33.70% |
| 2021-12-31 | $1.06B | $0.36B | 33.96% |
| 2021-09-30 | $1.02B | $0.35B | 34.15% |
| 2021-06-30 | $0.98B | $0.34B | 34.99% |
| 2021-03-31 | $0.94B | $0.33B | 35.31% |
| 2020-12-31 | $0.96B | $0.34B | 35.04% |
| 2020-09-30 | $0.96B | $0.34B | 35.25% |
| 2020-06-30 | $0.96B | $0.33B | 34.69% |
| 2020-03-31 | $0.96B | $0.32B | 33.54% |
| 2019-12-31 | $0.95B | $0.10B | 10.07% |
| 2019-09-30 | $0.95B | $0.10B | 10.29% |
| 2019-06-30 | $0.95B | $0.10B | 10.70% |
| 2019-03-31 | $0.98B | $0.11B | 10.77% |
| 2018-12-31 | $0.99B | $0.24B | 23.94% |
| 2018-09-30 | $1.02B | $0.24B | 23.82% |
| 2018-06-30 | $1.04B | $0.25B | 23.87% |
| 2018-03-31 | $1.04B | $0.26B | 24.47% |
| 2017-12-31 | $1.03B | $0.33B | 32.23% |
| 2017-09-30 | $0.97B | $0.31B | 32.27% |
| 2017-06-30 | $0.93B | $0.31B | 33.12% |
| 2017-03-31 | $0.88B | $0.24B | 27.18% |
| 2016-12-31 | $0.85B | $0.25B | 29.65% |
| 2016-09-30 | $0.83B | $0.25B | 29.53% |
| 2016-06-30 | $0.82B | $0.24B | 29.61% |
| 2016-03-31 | $0.81B | $0.29B | 36.35% |
| 2015-12-31 | $0.79B | $0.29B | 36.55% |
| 2015-09-30 | $0.79B | $0.28B | 36.01% |
| 2015-06-30 | $0.76B | $0.26B | 33.77% |
| 2015-03-31 | $0.72B | $0.23B | 32.73% |
| 2014-12-31 | $0.67B | $0.21B | 32.04% |
| 2014-09-30 | $0.62B | $0.20B | 32.36% |
| 2014-06-30 | $0.60B | $0.21B | 34.28% |
| 2014-03-31 | $0.60B | $0.21B | 35.62% |
| 2013-12-31 | $0.61B | $0.22B | 36.14% |
| 2013-09-30 | $0.62B | $0.23B | 36.71% |
| 2013-06-30 | $0.62B | $0.23B | 36.53% |
| 2013-03-31 | $0.62B | $0.22B | 35.48% |
| 2012-12-31 | $0.60B | $0.19B | 31.67% |
| 2012-09-30 | $0.55B | $0.16B | 28.96% |
| 2012-06-30 | $0.49B | $0.14B | 27.38% |
| 2012-03-31 | $0.44B | $0.12B | 26.30% |
| 2011-12-31 | $0.40B | $0.11B | 27.54% |
| 2011-09-30 | $0.39B | $0.10B | 25.77% |
| 2011-06-30 | $0.36B | $0.10B | 26.39% |
| 2011-03-31 | $0.34B | $0.09B | 26.49% |
| 2010-12-31 | $0.31B | $0.09B | 29.32% |
| 2010-09-30 | $0.29B | $0.10B | 34.48% |
| 2010-06-30 | $0.29B | $0.10B | 33.11% |
| 2010-03-31 | $0.29B | $0.10B | 32.42% |
| 2009-12-31 | $0.28B | $0.09B | 32.51% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $3.221B | $1.138B |
| Prestige Consumer Healthcare Inc. is a consumer healthcare products company. Its diverse portfolio of brands include Monistat(R) and Summer's Eve(R) women's health products, BC(R) and Goody's(R) pain relievers, Clear Eyes(R) and TheraTears(R) eye care products, DenTek(R) specialty oral care products, Dramamine(R) motion sickness treatments, Fleet(R) enemas and glycerin suppositories, Chloraseptic(R) and Luden's(R) sore throat treatments and drops, Compound W(R) wart treatments, Little Remedies(R) pediatric over-the-counter products, Boudreaux's Butt Paste(R) diaper rash ointments, Nix(R) lice treatment, Debrox(R) earwax remover, Gaviscon(R) antacid in Canada, and Hydralyte(R) rehydration products and the Fess(R) line of nasal and sinus care products in Australia. Prestige Consumer Healthcare Inc., formerly known as Prestige Brands Holdings Inc., is based in Tarrytown, New York. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $229.741B | 26.94 |
| Boston Scientific (BSX) | United States | $155.895B | 37.18 |
| Stryker (SYK) | United States | $147.123B | 29.95 |
| EssilorLuxottica (ESLOY) | France | $145.891B | 0.00 |
| Medtronic (MDT) | Ireland | $116.772B | 16.47 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.160B | 0.00 |
| Haleon (HLN) | United Kingdom | $44.031B | 25.15 |
| ResMed (RMD) | United States | $42.217B | 30.19 |
| GE HealthCare Technologies (GEHC) | United States | $33.398B | 15.70 |
| Agilent Technologies (A) | United States | $33.278B | 21.69 |
| Terumo (TRUMY) | Japan | $27.302B | 32.35 |
| Koninklijke Philips (PHG) | Netherlands | $26.423B | 17.48 |
| Insulet (PODD) | United States | $23.078B | 77.32 |
| Zimmer Biomet Holdings (ZBH) | United States | $20.685B | 13.17 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $16.192B | 0.00 |
| Baxter (BAX) | United States | $12.250B | 9.46 |
| Sunny Optical Technology (SNPTF) | China | $10.800B | 0.00 |
| Demant (WILYY) | Denmark | $8.121B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.714B | 28.33 |
| Lantheus Holdings (LNTH) | United States | $4.023B | 10.88 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.400B | 23.79 |
| Perrigo (PRGO) | Ireland | $3.224B | 8.05 |
| ICU Medical (ICUI) | United States | $3.005B | 20.46 |
| Haemonetics (HAE) | United States | $2.601B | 11.61 |
| LeMaitre Vascular (LMAT) | United States | $2.183B | 46.82 |
| Acuren (TIC) | United States | $2.054B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $1.918B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.804B | 77.48 |
| AtriCure (ATRC) | United States | $1.776B | 0.00 |
| QuidelOrtho (QDEL) | United States | $1.742B | 10.97 |
| Phibro Animal Health (PAHC) | United States | $1.279B | 16.35 |
| AdaptHealth (AHCO) | United States | $1.261B | 17.92 |
| Tilray Brands (TLRY) | Canada | $1.222B | 0.00 |
| Neogen (NEOG) | United States | $1.216B | 19.31 |
| BioLife Solutions (BLFS) | United States | $1.201B | 2508.00 |
| Valneva SE (VALN) | France | $0.952B | 0.00 |
| InMode (INMD) | Israel | $0.898B | 8.31 |
| Kestra Medical Technologies (KMTS) | United States | $0.876B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.622B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.609B | 0.00 |
| SNDL (SNDL) | Canada | $0.589B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.587B | 0.00 |
| ZimVie (ZIMV) | United States | $0.534B | 20.58 |
| Surmodics (SRDX) | United States | $0.516B | 0.00 |
| Evolus (EOLS) | United States | $0.480B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.471B | 16.20 |
| CeriBell (CBLL) | United States | $0.428B | 0.00 |
| Owens & Minor (OMI) | United States | $0.392B | 3.48 |
| Sanuwave Health (SNWV) | United States | $0.354B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.321B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| Omeros (OMER) | United States | $0.305B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.303B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.297B | 0.00 |
| Brainsway (BWAY) | Israel | $0.283B | 57.65 |
| Viemed Healthcare (VMD) | United States | $0.273B | 20.74 |
| High Tide (HITI) | Canada | $0.273B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.272B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.270B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.231B | 0.00 |
| Cerus (CERS) | United States | $0.230B | 0.00 |
| Quanterix (QTRX) | United States | $0.225B | 0.00 |
| Exagen (XGN) | United States | $0.220B | 0.00 |
| Organigram Global (OGI) | Canada | $0.210B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.209B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.188B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.184B | 15.37 |
| FitLife Brands (FTLF) | United States | $0.155B | 19.10 |
| Biote (BTMD) | United States | $0.149B | 4.95 |
| Jushi Holdings (JUSHF) | United States | $0.131B | 0.00 |
| Fonar (FONR) | United States | $0.094B | 12.17 |
| Quipt Home Medical (QIPT) | United States | $0.092B | 0.00 |
| MacroGenics (MGNX) | United States | $0.091B | 0.00 |
| Jin Medical (ZJYL) | China | $0.089B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.084B | 0.00 |
| Apyx Medical (APYX) | United States | $0.078B | 0.00 |
| Safety Shot (SHOT) | United States | $0.068B | 0.00 |
| Agape ATP (ATPC) | $0.066B | 0.00 | |
| ImmuCell (ICCC) | United States | $0.054B | 31.47 |
| Cytosorbents (CTSO) | United States | $0.053B | 0.00 |
| Veru (VERU) | United States | $0.052B | 0.00 |
| Zynex (ZYXI) | United States | $0.046B | 0.00 |
| Nephros (NEPH) | United States | $0.043B | 33.50 |
| Rockwell Medical (RMTI) | United States | $0.040B | 0.00 |
| Modular Medical (MODD) | United States | $0.039B | 0.00 |
| United-Guardian (UG) | United States | $0.038B | 14.82 |
| Trinity Biotech (TRIB) | Ireland | $0.028B | 0.00 |
| Senestech (SNES) | United States | $0.022B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Allurion Technologies (ALUR) | United States | $0.015B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.014B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Flora Growth (FLGC) | United States | $0.012B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.011B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| Sharps Technology (STSS) | United States | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.005B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |